StockNews.com upgraded shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a hold rating to a buy rating in a report published on Saturday morning.
Kewaunee Scientific Stock Performance
Shares of Kewaunee Scientific stock opened at $36.61 on Friday. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $34.92 and a two-hundred day moving average price of $41.60. Kewaunee Scientific has a 1-year low of $16.51 and a 1-year high of $55.62. The company has a market cap of $105.07 million, a P/E ratio of 6.08 and a beta of 0.73.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last issued its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.87% and a net margin of 9.13%. The firm had revenue of $48.39 million during the quarter.
Hedge Funds Weigh In On Kewaunee Scientific
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Read More
- Five stocks we like better than Kewaunee Scientific
- Transportation Stocks Investing
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is a Death Cross in Stocks?
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is the Shanghai Stock Exchange Composite Index?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.